A key area of our work is to be part of vital research and give funds towards research.

  • Mike Bray Fellowship Award

    Action for Pulmonary Fibrosis is leading the way to finding new treatments with the Mike Bray Fellowship Award. "The two projects seek to understand different aspects of the disease and we hope they will each open up new avenues for treatment. As a charity we work hard to increase awareness of the disease and encourage greater investment in finding effective treatments and, ultimately, a cure."

    Read more here
  • Pulmonary Fibrosis and IPF Research reports & updates

    Action for Pulmonary Fibrosis are pleased to be able to support researchers in the field of (Idiopathic) Pulmonary Fibrosis to attend research events both in the UK and overseas. You can read reports and updates from these researchers here.

    Read our research updates and reports
  • Improving Symptom Control and QoL in patients with ILD (Full report)

    Patients with fibrotic interstitial lung diseases (ILD) have a high symptom burden. Improvements in symptom management may decrease hospital admissions and increase Quality of Life (QoL). This systematic review aimed to examine the interventions to improve symptom control and quality of life in patients with ILD.

    Read the full report
  • IPF Report

    We met with the All-Party Parliamentary Respiratory Group and other MPs to launch our report and to call for immediate action by NHS England to improve care for IPF patients and to mandate data collection of people diagnosed with the disease.

    Read more about the IPF report
  • 100,000 Genomes Project

    Drs Jenkins and Parfrey, two of our trustees – are leaders in the field of IPF research in the UK – and are involved in research studies investigating the genetics of IPF as part of the 100,000 Genome Project and the UK Interstitial lung disease IPF consortium.

    Read more about the Genomes Project
  • APF trustee awarded prestigious NIHR Professorship

    APF is pleased to congratulate Professor Gisli Jenkins, one of our trustees, on being awarded a NIHR professorship for research on pulmonary fibrosis. Gisli has been granted a £1.7million, five-year project to identify biomarkers that could predict the course of the disease.

    Read about the award
  • PhD Opportunity on design and conduct of clinical trials

    Action for Pulmonary Fibrosis is co-operating with the University of East Anglia (UEA) on a research study on Idiopathic Pulmonary Fibrosis. As part of the overall study, there is a PhD research opportunity at UEA to study novel methods of patient recruitment for multi-centre clinical trials.

    Read more here